West Midlands Academic Health Science Network July 24 th 2013

1. West Midlands Academic Health Science Network July 24th 2013

2. West Midlands Academic Health Science NetworkOverview Andy Hardy CEO University Hospitals Coventry and Warwickshire NHS Trust Chair – West Midlands AHSN interim board

3. Background • Innovation, Health & Wealth – publishedDecember 11 set out a plan for spreading innovation through the NHS • Focus that innovation is vital in order to transform healthcare • Aim to rapidly spread change to improve quality, safety and productivity

4. Role and purpose of AHSNs • Improve the identification, adoption, spread, speed of innovation and good practice in the NHS • Provide the opportunity to align education and training, clinical research, informatics, innovation and healthcare delivery • Enable the NHS and academia to work collaboratively with industry • Overall purpose to improve patient outcomes and create wealth • Succeed where others have not

5. West Midlands - background • 5.6m diverse population • Inequality in health outcomes and healthcare delivery • Academic & clinical excellence, established regional networks and collaborations • Industrial heritage that will drive wealth creation

6. WM AHSN aims • To transform the identification, adoption spread and spead of innovation and good practice • To align healthcare delivery, research, education and training • To drive wealth creation through the development of a regional industry portal enabling access to the NHS, driving adoption and publishing evaluation • To improve outcomes - driventhrough use of digital platforms

7. Strategy & vision – 6 enabling themes • Develop a novel and comprehensive digital framework • Establish regional clinical trials platforms - support for acceleration, reducing bureaucracy, improving efficiency and cost effectiveness • To promote and accelerate innovation, evaluation and adoption • To drive and develop patient-centric integrated care pathways - bridging primary, secondary & social care • Focus on education & training - delivering a fit for purpose workforce in partnership with LETB • To create wealth - proactive support for regional medical technology industry engagement

8. Initial focus on 3 clinical priorities • Mental health • In the young • Dementia (carers, community management) • Chronic disease • Diabetes & obesity • Musculoskeletal disease • Drug safety • From hospital to primary care • Abolishing prescribing errors across the region

9. 6 High Impact Innovations Innovations that ‘will make a real difference to the quality and experience of people’s lives, as well as delivering productivity improvements’ • 3 million lives – assistive technology – telehealth/telecare use • Intra-operative fluid management (IOFM) – involving NTAC guidelines/technology adoption • Child in a chair in a day • International & commercial activity – IP policy and systems in place with plans for increasing exploitation where possible • Digital first – reducing face-to-face contact • Carers for people with dementia – signposting carers to information

10. Role of the WM AHSN with HII’s • Circulating existing information relating to each HII (web links, documents) • Supporting providers to measure their baseline – i.e. sharing how others are defining it, signposting to performance datasets etc. • Sharing good practice examples from around the region and nationally • Ascertaining barriers to adoption so the AHSN can influence at a regional level with commissioners if required • Running events/workshops/webinars to enable providers to share baseline data and set appropriate trajectories (peer review) • Disseminating progress within 13/14

11. Organisations involved in AHSN development to date • University Hospitals Coventry and Warwickshire NHS Trust • University Hospitals Birmingham NHS Foundation Trust • University of Birmingham • Keele University • Birmingham and Solihull Mental Health Foundation Trust • University Hospital North Staffordshire NHS Foundation Trust • University of Warwick • Heart of England NHS Foundation Trust • West Midlands South CLRN • Medilink West Midlands

12. Organisation & governance

13. Proposed AHSN board – from September 2013 • Chair • MD • COO • Spoke chairs x 3 and hub chair x 1 • HEIs x 3 • MH / community trust CEO • Commercial representative • LETB (non voting) • CRN (non voting)

14. Current position • Designated without condition on 13th May 2013 (7 of the 15 had conditions) • £4.63 million funding for 2013/14 – given in two parts (£3.2m in July and £1.43 later) • Discussions regarding on further funding on-going • Meetings with NHS England and the AHSNs planned for early July to discuss the licence and development requirements • Commencing WM AHSN key stakeholder meetings http://www.wmahsn.org

15. Our hope 5 years on… • To have an integrated & innovative health network – not just in words • To be the first UK regional digital healthcare economy • To be the known place for industry for NHS access, evaluation and adoption • To be significantly on the road to reversing health inequality and to have significantly improved outcomes for the region

16. West Midlands Academic Health Science Network • Queries and notifications - email info@wmahsn • Further information, news and events - website www,wmahsn.org • Latest news and connecting with others with common interests - follow us on Twitter @wmahsn